Benzinga Bulls and Bears: Palo Alto, Ciena, Lululemon
Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a look at some of our top stories.
Stocks · News reference
Tradr Bets on Quantum Boom With 5 New 2X ETFs on Quantinuum, Ciena
The new 2X leveraged single-stock ETFs track Quantinuum, Ciena, Rambus, Tower Semiconductor, and TTM Technologies, expanding its $10B leveraged ETF lineup.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Ciena Posts Blowout Q3, So Why Are These Analysts Slashing Price Targets?
Ciena shares rise after a strong Q3 beat. Analysts keep Buy ratings but cut targets. Analysts cite $8.5B backlog and $10B yearend outlook.
B. Riley Securities Maintains Neutral on Ciena, Lowers Price Target to $347
B. Riley Securities analyst Dave Kang maintains Ciena (NYSE:CIEN) with a Neutral and lowers the price target from $413 to $347.
JP Morgan Maintains Overweight on Ciena, Lowers Price Target to $605
QUBT Bets on Scale as Rising Costs Weigh on Profitability
Quantum Computing Inc. (QUBT) reported strong revenue growth to $5.6M in Q2 2026 but remains unprofitable with a $1.2M gross loss. The company spent $180M on three acquisitions, expanding capabilities but introducing integration risks. Operating expenses surged 114% YoY. Peers D-Wave and Rigetti also face challenges with uneven revenues tied to large contracts and high expense intensity relative to their revenue bases.
D-Wave Quantum's Massive Upside Meets a High-Stakes Valuation Reality
D-Wave Quantum is transitioning from demonstrations to live enterprise workloads with growing production revenue and contracted revenue. However, the stock's current valuation already prices in a much larger future business, leaving little room for error. The company faces a tension between its promising operational progress and its high-stakes valuation.